Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,369,594 entitled, "Cytotoxic Actin-Targeting Compounds," on June 28, 2022 to Madhu Aeluri, John Allingham, Andrew Craig, Andrew Evans, and Rebecca Grange. The patent relates to a class of compounds useful in pharmaceutical compositions and methods for treating or preventing cancer.
U.S. Patent No. 11,369,594 (PDF, 4.3 MB)US11369594_Grange.pdf